Delivery Order SPE2DB22D1002-SPE2DB25FLGF7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was issued on July 25, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) on September 18, 2025, with an ultimate completion date of October 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract valued at $4,027.70. The delivery order is scheduled for completion by October 1, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order placed against AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for $8,055.40 on August 21, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). The contract represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) with a ceiling value of $8,055.40. This firm fixed price delivery order, with an ultimate completion date of October 2, 2025, represents a non-competitive set-aside award and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,027.70 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ingrezza 40 mg capsules (30-count) with a ceiling value of $3,676.12. This is a firm fixed price delivery order with an ultimate completion date of September 24, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ingrezza 60 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,049.61. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of May 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) on May 2, 2025, with an ultimate completion date of May 23, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major healthcare solutions provider and critical vendor for federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGF7Delivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count) on August 12, 2025, with a ceiling value of $4,027.70 and an ultimate completion date of September 3, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to the pharmaceutical distributor for a neurological medication used in the treatment of tardive dyskinesia. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider for federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a diverse range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. The current delivery order exemplifies the ongoing utilization of this strategic contract vehicle for specialized pharmaceutical fulfillment across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/12/25 |